Pacira BioSciences, Inc.

NasdaqGS:PCRX Stock Report

Market Cap: US$1.2b

Pacira BioSciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:PCRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Mar 24SellUS$3,656,226Gary PaceIndividual119,323US$30.81
02 Aug 23SellUS$17,751Roy WinstonIndividual509US$34.88
07 Jun 23SellUS$87,435Ronald EllisIndividual2,276US$38.99
07 Jun 23SellUS$79,560Dennis McLoughlinIndividual2,071US$38.99
07 Jun 23SellUS$46,369Lauren RikerIndividual1,207US$38.99
07 Jun 23SellUS$36,919Jonathan SloninIndividual961US$38.99
07 Jun 23SellUS$139,680Roy WinstonIndividual3,636US$38.99
07 Jun 23SellUS$398,885David StackIndividual10,384US$38.99
07 Jun 23SellUS$82,710Max ReinhardtIndividual2,153US$38.99
07 Jun 23SellUS$78,831Daryl GauglerIndividual2,052US$38.99
07 Jun 23SellUS$102,110Kristen DunkerIndividual2,658US$38.99
07 Jun 23SellUS$100,106Charles ReinhartIndividual2,607US$38.99
05 Jun 23SellUS$86,774Anthony MolloyIndividual2,267US$38.28
05 Jun 23SellUS$22,237Paul HastingsIndividual580US$38.34

Insider Trading Volume

Insider Buying: PCRX insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of PCRX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies20,5130.0409%
State or Government27,9820.0558%
Individual Insiders430,9590.86%
Institutions49,630,11399%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 76.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.5%
BlackRock, Inc.
8,114,251US$218.0m8.09%no data
11%
The Vanguard Group, Inc.
5,098,424US$137.0m2.86%no data
4.48%
Frontier Capital Management Co LLC
2,084,542US$56.0m15.8%0.49%
4.16%
State Street Global Advisors, Inc.
1,936,158US$52.0m8.45%no data
3.69%
Renaissance Technologies LLC
1,716,697US$46.1m6.36%0.07%
3.04%
Dimensional Fund Advisors LP
1,411,767US$37.9m1.29%0.01%
2.98%
Macquarie Investment Management Business Trust
1,384,163US$37.2m-16.7%0.04%
2.83%
Stephens Investment Management Group, LLC
1,318,005US$35.4m-1.91%0.49%
2.58%
Vestal Point Capital, LP
1,200,000US$32.2m0%3.51%
2.46%
ClearBridge Investments, LLC
1,145,687US$30.8m-0.33%0.02%
2.29%
Baillie Gifford & Co.
1,063,266US$28.6m-35.1%0.01%
2.27%
Rock Springs Capital Management LP
1,055,500US$28.4m0%0.78%
2.24%
Pacer Advisors, Inc.
1,041,679US$28.0m397,000%0.08%
2.23%
Rice Hall James & Associates, LLC
1,035,969US$27.8m6.97%1.67%
2.16%
Geode Capital Management, LLC
1,003,617US$27.0m4.94%no data
1.34%
Schroder Investment Management North America Inc.
621,709US$16.7m-6.88%0.05%
1.3%
Janus Henderson Group plc
604,033US$16.2m12.3%0.01%
1.17%
Gagnon Securities, LLC
545,579US$14.7m-3.51%3.62%
1.14%
Northern Trust Global Investments
528,261US$14.2m4.88%no data
1.06%
Rubric Capital Management LP
491,322US$13.2m6.89%0.43%
1.03%
Marshall Wace LLP
480,193US$12.9m-1.12%0.03%
0.98%
Morgan Stanley, Investment Banking and Brokerage Investments
456,073US$12.3m56.8%no data
0.97%
HBM Partners Ltd.
451,324US$12.1m0%1.41%
0.96%
abrdn plc
448,691US$12.1m14.3%0.01%
0.96%
Invesco Capital Management LLC
445,813US$12.0m5.86%0.01%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.